Nuvalent Inc vs Direxion NASDAQ 100 Equal Weighted Index Shares — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Direxion NASDAQ 100 Equal Weighted Index Shares trades at $118.11. The key difference: Nuvalent Inc is trading nearer its 52-week high, Direxion NASDAQ 100 Equal Weighted Index Shares nearer its low. Which is the better fit depends on your goals.
| NUVL | QQQE | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $123.96 | $122.72 |
52-Week Low | $72.16 | $96.06 |
Enterprise Value | $8.52B | — |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →QQQE is an ETF that seeks to track the performance of the NASDAQ-100 Equal Weighted Index. Unlike traditional market-capitalization-weighted indexes, this fund assigns equal weight to each of the 100 non-financial companies in the NASDAQ-100 and rebalances quarterly. This equal-weighting scheme reduces concentration risk in the largest technology companies and increases the fund's exposure to smaller-cap and mid-cap companies within the index, providing a differentiated growth profile.
Read more on QQQE →